Achieve Life Sciences Gross Profit 2006-2020 | ACHV

Achieve Life Sciences gross profit from 2006 to 2020. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Achieve Life Sciences Annual Gross Profit
(Millions of US $)
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $27
2013 $30
2012 $20
2011 $5
2010 $14
2009 $26
2008 $
2007 $
2006 $
2005 $8
Achieve Life Sciences Quarterly Gross Profit
(Millions of US $)
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30 $2
2016-03-31 $3
2015-12-31
2015-09-30 $7
2015-06-30 $4
2015-03-31 $1
2014-12-31 $6
2014-09-30 $5
2014-06-30 $5
2014-03-31 $12
2013-12-31 $9
2013-09-30 $10
2013-06-30 $6
2013-03-31 $5
2012-12-31 $10
2012-09-30 $7
2012-06-30 $2
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $2
2011-03-31 $1
2010-12-31 $2
2010-09-30 $5
2010-06-30 $2
2010-03-31 $5
2009-12-31
2009-09-30
2009-06-30
2009-03-31
2008-12-31
2008-09-30
2008-06-30
2008-03-31
2007-12-31
2007-09-30
2007-06-30 $3
2007-03-31 $5
2006-12-31
2006-09-30 $5
2006-06-30 $8
2006-03-31 $4
2005-12-31
2005-09-30
2005-06-30
2005-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.000B
Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.622B 43.60
Takeda Pharmaceutical (TAK) Japan $57.348B 9.99
Astellas Pharma (ALPMY) Japan $29.230B 14.81
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 20.80
Merck (MKGAF) Germany $17.222B 22.58
Catalent (CTLT) United States $13.660B 52.81
Grifols, S.A (GRFS) Spain $12.713B 15.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.819B 41.88
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.894B 50.01
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $7.047B 11.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.983B 11.52
Arrowhead Pharmaceuticals (ARWR) United States $4.196B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
Hypermarcas (HYPMY) Brazil $4.097B 15.07
Nektar Therapeutics (NKTR) United States $3.829B 0.00
FibroGen (FGEN) United States $3.693B 0.00
ChemoCentryx (CCXI) United States $3.370B 0.00
PTC Therapeutics (PTCT) United States $3.183B 0.00
Sage Therapeutics (SAGE) United States $2.596B 0.00
Pacira BioSciences (PCRX) United States $2.448B 65.32
Taro Pharmaceutical Industries (TARO) Israel $2.420B 11.71
Cronos Group (CRON) Canada $2.054B 0.00
Xencor (XNCR) United States $1.833B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.791B 0.00
USANA Health Sciences (USNA) United States $1.735B 16.35
Corcept Therapeutics (CORT) United States $1.614B 14.86
Ironwood Pharmaceuticals (IRWD) United States $1.608B 11.21
Indivior (INVVY) United States $1.606B 19.93
Revolution Medicines (RVMD) United States $1.513B 0.00
Akebia Therapeutics (AKBA) United States $1.441B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 13.34
Heron Therapeutics (HRTX) United States $1.391B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.315B 0.00
Zogenix (ZGNX) United States $1.311B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.138B 0.00
Karyopharm Therapeutics (KPTI) United States $1.121B 0.00
Esperion Therapeutics (ESPR) United States $1.065B 0.00
VAXART, INC (VXRT) United States $0.992B 0.00
Tilray (TLRY) Canada $0.969B 0.00
Translate Bio (TBIO) United States $0.957B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.926B 578.88
Altimmune (ALT) United States $0.848B 0.00
Endo (ENDP) Ireland $0.813B 1.20
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.706B 0.00
ImmunoGen (IMGN) United States $0.688B 0.00
Flexion Therapeutics (FLXN) United States $0.634B 0.00
Trillium Therapeutics (TRIL) Canada $0.625B 0.00
Collegium Pharmaceutical (COLL) United States $0.613B 0.00
Aerie Pharmaceuticals (AERI) United States $0.562B 0.00
Radius Health (RDUS) United States $0.539B 0.00
Siga Technologies (SIGA) United States $0.528B 0.00
Molecular Templates (MTEM) United States $0.509B 0.00
Ardelyx (ARDX) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.487B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 18.34
DURECT (DRRX) United States $0.467B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.455B 0.00
Ocular Therapeutix (OCUL) United States $0.451B 0.00
TherapeuticsMD (TXMD) United States $0.437B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.429B 10.36
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
Organogenesis Holdings (ORGO) United States $0.410B 0.00
Calithera Biosciences (CALA) United States $0.353B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.318B 0.00
IMV INC (IMV) Canada $0.313B 0.00
OptiNose (OPTN) United States $0.292B 0.00
MEI Pharma (MEIP) United States $0.288B 0.00
PROFOUND MEDICL (PROF) Canada $0.286B 0.00
Redhill Biopharma (RDHL) Israel $0.282B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Lannett Co Inc (LCI) United States $0.248B 5.44
CASI Pharmaceuticals (CASI) United States $0.230B 0.00
Aquestive Therapeutics (AQST) United States $0.204B 0.00
KalVista Pharmaceuticals (KALV) United States $0.200B 0.00
Nivalis Therapeutics (ALPN) United States $0.199B 0.00
Nature's Sunshine Products (NATR) United States $0.196B 25.82
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.187B 0.00
Onconova Therapeutics (ONTX) United States $0.180B 0.00
Heat Biologics (HTBX) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.90
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.141B 0.00
Xeris Pharmaceuticals (XERS) United States $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
MediWound (MDWD) Israel $0.113B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Otonomy (OTIC) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Biomerica (BMRA) United States $0.104B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.098B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.097B 0.00
Recro Pharma (REPH) United States $0.097B 0.00
Hemispherx BioPharma (AIM) United States $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.094B 0.00
Lipocine (LPCN) United States $0.092B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
CV Sciences (CVSI) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.064B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Sundial Growers (SNDL) Canada $0.060B 0.00
Infinity Pharmaceuticals (INFI) United States $0.059B 0.00
Novan (NOVN) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.82
AgeX Therapeutics (AGE) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
GTx (ONCT) United States $0.044B 0.00
IsoRay (ISR) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.043B 8.16
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.09
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Vical (BBI) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 35.29
Shineco (TYHT) China $0.015B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00